Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.
By LINDA A. JOHNSON AP Medical Writer, Waco Tribune-Herald
Fri, 04/21/2017 - 3:49pm
Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.